GlaxoSmithKline reported GBP22.12B in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Alcon AG ALC:SW USD 4.33B 46M
Amgen AMGN:US USD 38.7B 2.18B
AstraZeneca AZN:LN USD 29.3B 229M
Bayer BAYN:GR EUR 44.79B 157M
Biogen BIIB:US USD 6.28B 998M
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Eli Lilly And LLY:US USD 15.89B 925.4M
Fresenius FRE:GR EUR 28.61B 239M
Fresenius Medical Care FME:GR EUR 13.79B 126.54M
Galapagos GLPG:NA EUR 22.68M 1.37M
Genmab GEN:DC DKK 629M 5M
Gilead Sciences GILD:US USD 25.22B 993M
GlaxoSmithKline GSK:LN GBP 22.12B 4M
Glaxosmithkline GSK:US GBP 22.12B 4M
Hikma Pharmaceutical HIK:LN USD 1.55B 705M
Lonza Group LONN:SW CHF 2.23B 171M
Merck MRK:GR EUR 11.02B 783M
Merk MRK:US USD 30.42B 1.25B
Novartis NOVN:VX USD 28.44B 2.59B
Orion ORNBV:FH EUR 215M 38.6M
Pfizer PFE:US USD 36.67B 3.62B
Recordati REC:IM EUR 1.7B 127.57M
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Roche Holding ROG:VX 27.75B 3.45B
Smith & Nephew PLC SN/:LN 2.89B 446M